Effect of intravenous pulse dexamethasone versus daily oral prednisolone on bone mineral density in dermatology patients: Is it a site-specific response? | Zendy

Sanjeev Handa | Zendy; Gurjeet Singh | Zendy; Amanjot Kaur Arora | Zendy; Niranjan Khandelwal | Zendy; V. Gupta | Zendy

Open Access

Effect of intravenous pulse dexamethasone versus daily oral prednisolone on bone mineral density in dermatology patients: Is it a site-specific response?

Author(s) -

Sanjeev Handa,

Gurjeet Singh,

Amanjot Kaur Arora,

Niranjan Khandelwal,

V. Gupta

Publication year - 2017

Publication title -

indian journal of dermatology venereology and leprology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.514

H-Index - 45

eISSN - 0973-3922

pISSN - 0378-6323

DOI - 10.4103/0378-6323.204202

Subject(s) - medicine , bone mineral , dexamethasone , osteoporosis , prednisolone , osteopenia , group b , bone density , anesthesia , surgery

The use of glucocorticoids in various forms of administration is complicated by their systemic side effects. Although intravenous pulse therapy is considered to have lesser systemic side effects, there are few studies in literature comparing the effects of intravenous pulse glucocorticoids versus oral daily glucocorticoids on bone mineral density.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research